CompletedNCT00393978
Quetiapine with topiramate for cannabis use and mania in bipolarity
About this title
Read the official source — NCT00393978Medication studyAges 12–21United States
Understand this study
Who was this study for?
Listed age limits: 12 years to 21 years.
- Listed locations
- CincinnatiSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateNovember 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- 75
- Sponsor
- University of Cincinnati
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- United States
- Age range
- From 12 Years to 21 Years
- Official registry ID
- NCT00393978
- Official title
Show the full official title
Quetiapine Plus Topiramate or Placebo for Bipolar Mania & Cannabis Use in Adolescents
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Cincinnati
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Cincinnati, a university.
Did this study involve medication?
Yes. The study involved medication, including Quetiapine and placebo and Quetiapine and Topiramate.
Who was this study for?
Listed age limits: 12 years to 21 years.
